Cargando…

Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses

Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype. Non-available targeted therapy for TNBC represents its biggest treatment challenge. Thus, finding new promising effective drugs is urgently needed. In the present study, we investigated how berberine, a natural isoquinoline...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Khalki, Lamyae, Maire, Virginie, Dubois, Thierry, Zyad, Abdelmajid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036777/ https://www.ncbi.nlm.nih.gov/pubmed/31991634 http://dx.doi.org/10.3390/molecules25030506

Ejemplares similares

Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine
por: El khalki, Lamyae, et al.
Publicado: (2018)

In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
por: Bouchmaa, Najat, et al.
Publicado: (2023)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Cellular and Molecular Mechanisms and Effects of Berberine on Obesity-Induced Inflammation
por: Noh, Ji-Won, et al.
Publicado: (2022)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

Olive Mill Waste Extracts: Polyphenols Content, Antioxidant, and Antimicrobial Activities
por: Leouifoudi, Inass, et al.
Publicado: (2015)

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018)

Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
por: Yao, Mingjiang, et al.
Publicado: (2019)

Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids
por: Tilaoui, Mounir, et al.
Publicado: (2021)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Overall survival of triple negative breast cancer in French Caribbean women
por: Beaubrun-Renard, Murielle Murielle, et al.
Publicado: (2022)

Atheroprotective Effects and Molecular Mechanism of Berberine
por: Xing, Lu, et al.
Publicado: (2021)

Involvement of mitochondrial and survival signaling in berberine-induced apoptosis in melanoma cells
por: Burgeiro, Ana, et al.
Publicado: (2010)

Differential Effect of Artemisinin Against Cancer Cell Lines
por: Tilaoui, Mounir, et al.
Publicado: (2014)

Comparative Phytochemical Analysis of Essential Oils from Different Biological Parts of Artemisia herba alba and Their Cytotoxic Effect on Cancer Cells
por: Tilaoui, Mounir, et al.
Publicado: (2015)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
por: Zajac, Olivier, et al.
Publicado: (2020)

Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
por: Yin, Jianyun, et al.
Publicado: (2022)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Identifying survival associated morphological features of triple negative breast cancer using multiple datasets
por: Wang, Chao, et al.
Publicado: (2013)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Molecular and Crystal Structures of Three Berberine Derivatives
por: Man, Stanislav, et al.
Publicado: (2001)

A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries
por: Madihi, Salma, et al.
Publicado: (2020)

Performance Comparison of the artus HBV QS-RGQ and the CAP/CTM HBV v2.0 Assays regarding Hepatitis B Virus DNA Quantification
por: Madihi, Salma, et al.
Publicado: (2020)

Berberine and Berberine-Containing Plants in Pharmacology and Therapeutics
por: Chopra, R. N., et al.
Publicado: (1932)

Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
por: Jiang, Xiaotao, et al.
Publicado: (2018)

Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses
por: Xiao, Xiao, et al.
Publicado: (2021)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
por: Tian, Erjie, et al.
Publicado: (2023)

Hyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healing
por: Amato, Giovanni, et al.
Publicado: (2020)

Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
por: Zhao, Kangrong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5mdpod9e13t79ae2a6fg1ss58